Future prospects of systemic host modulatory agents in periodontal therapy

Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease

(2012) João Antonio Chaves de Souza et al.   Journal of Applied Oral Science

Effect of anti-rheumatic agents on periodontal parameters and biomarkers of inflammation: a systematic review and meta-analysis

(2012) Ji Young Han et al.   Journal of Periodontal and Implant Science

S-Nitrosoglutathione Decreases Inflammation and Bone Resorption in Experimental Periodontitis in Rats

(2011) Adriana Magalhães Andrade de Menezes et al.   JOURNAL OF PERIODONTOLOGY

Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease

(2010) H.L. Neville-Webbe et al.   EUROPEAN JOURNAL OF CANCER

Therapeutic Efficacy of Vasoactive Intestinal Peptide inEscherichia coliLipopolysaccharide-Induced Experimental Periodontitis in Rats

(2009) Ali Gürkan et al.   JOURNAL OF PERIODONTOLOGY

Signaling pathways associated with the expression of inflammatory mediators activated during the course of two models of experimental periodontitis

(2009) Sabrina Garcia de Aquino et al.   LIFE SCIENCES

Anti–TNF-α Immunotherapy Is Associated With Increased Gingival Inflammation Without Clinical Attachment Loss in Subjects With Rheumatoid Arthritis

(2008) Jacques-Olivier Pers et al.   JOURNAL OF PERIODONTOLOGY

Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions

(2008) P. Boissy et al.   LEUKEMIA RESEARCH

Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6

(2008) Huang Hongming et al.   LEUKEMIA RESEARCH

Host response modulation in periodontics

(2008) Philip M. Preshaw   PERIODONTOLOGY 2000